Form CORRESP - Correspondence:
SEC Accession No. 0001193125-24-057765
Filing Date
2024-03-04
Accepted
2024-03-04 15:29:38
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 5743
2 GRAPHIC g496651dsp002.jpg GRAPHIC 8307
  Complete submission text file 0001193125-24-057765.txt   18269
Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1
Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888
enGene Holdings Inc. (Filer) CIK: 0001980845 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)